NCT01981889View on ClinicalTrials.gov

Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

August 31, 2016

Conditions
Inflammatory Bowel Disease 11
Interventions
DRUG

Prednisone

Participants will be started on oral prednisone 40mg/day for two weeks as per standard of practice in IBD management, before starting a tapering course.

Trial Locations (1)

V6Z 2K5

Pacific Gastroenterology Associates, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT01981889 - Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter